Questions discussed in this category
Would you ever consider this approach for an initially polymetastatic patient?
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
...
A021501 trial: mFOLFIRINOX vs mFOLFIRINOX with hypofractionated radiation (Katz et al., PMID 35834226)
Would you consider SBRT as post-chemo consolidation for a patient with a single unresectable focus of metastatic adenocarcinoma at the celiac axis?&nb...
1894517998153421494110237
Papers discussed in this category
JAMA,
J Clin Oncol, 2022 Jan 27
BMC Cancer, 2021 Mar 23
Int J Radiat Oncol Biol Phys, 2019 Jan 23
The New England journal of medicine, 2013-10-31
N. Engl. J. Med.,
Lancet, 2021 Jun 05
Eur J Cancer, 2018 Aug 24
NEJM Evidence, 2022 Jun 1
JAMA Oncol, 2022 Apr 1
Int J Radiat Oncol Biol Phys, 2023 Mar 01
Seminars in radiation oncology, 2002 Jul
Int J Radiat Oncol Biol Phys, 2022 Jul 04
Lancet (London, England), 2023 Dec 14